Structured evidence table for Chia Seed Cardiometabolic Markers Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chia Seed Cardiometabolic Markers Randomized Trial | Background Obesity is a significant public health issue associated with various chronic diseases. | 1 | Karimi M (2024) | Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs. |
| Chia Seed Cardiometabolic Markers Randomized Trial | This review aims to comprehensively analyze the available evidence on the effects of chia seeds on cardiometabolic indices in overweight populations through a meta-analysis. | 1 | Karimi M (2024) | Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs. |
| Chia Seed Cardiometabolic Markers Randomized Trial | However, chia seed supplementation was associated with a significant reduction in C-reactive protein (CRP) (MD: - 1.18 mg/L, p 2 , p = 0.91), but a significant reduction in waist circumference (WC) (MD: - 2.82 cm, p 2 Conclusion Chia seed supplementation does not significantly impact most lipid profile parameters and glycemic markers. | 1 | Karimi M (2024) | Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs. |
| Chia Seed Cardiometabolic Markers Randomized Trial | Research has indicated that chia seeds have the potential to improve cardiometabolic health. | 1 | Karimi M (2024) | Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs. |
| Chia Seed Cardiometabolic Markers Randomized Trial | It is often associated with hormonal imbalance, metabolic disturbances, and reproductive complications, which together contribute to an elevated risk of long-term cardiometabolic disorders. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Chia Seed Cardiometabolic Markers Randomized Trial | To narratively synthesize mechanistic rationale and human clinical evidence on dietary seeds and selected nutraceuticals relevant to PCOS, with emphasis on metabolic and reproductive endpoints of interest to nutrition and obstetrics/gynecology practice. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Chia Seed Cardiometabolic Markers Randomized Trial | Proposed "seed cycling" protocols have received attention, yet most clinical data are derived from mixed-seed supplementation studies or low-level evidence, such as case reports, and should be considered hypothesis-generating. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Chia Seed Cardiometabolic Markers Randomized Trial | Polycystic ovary syndrome (PCOS) represents one of the most common endocrine disorders among women of reproductive age. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
Source documents